Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07734519 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pelashield vs Xeroform

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 4 more changesShow less
    • Start date changed from estimate of Oct 2026 to Sep 30, 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised
  2. Start date: Aug 2026 to Oct 2026v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to compare the effects (good or bad) of a new skin graft dressing (PelashieldTM) compared to the one traditionally used (Xeroform).
Trial Details
NCT Number NCT07734519
Lead Sponsor Wake Forest University Health Sciences
Conditions
(from sponsor)		 Skin Graft
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov